Ticker Details
Insulet Corporation Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.
IPO Date:	May 15, 2007
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$10.96B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.93 | 1.99%
Avg Daily Range (30 D):	$3.89 | 2.57%
Avg Daily Range (90 D):	$4.11 | 2.34%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	1.15M
Avg Daily Volume (90 D):	1.05M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	43
Avg Trade Size (Sh.) (90 D):	37

Institutional Trades
Total Institutional Trades:	10,326
Avg Institutional Trade:	$6.39M
Avg Institutional Trade (30 D):	$17.96M
Avg Institutional Trade (90 D):	$15.64M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$11.82M
Avg Closing Trade (30 D):	$49.49M
Avg Closing Trade (90 D):	$39.56M
Avg Closing Volume:	62.94K

News

Jul 9, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges Insulet Co... Source: Bronstein, Gewirtz & Grossman Llc

Jul 9, 2026 @ 1:56 AM GDDY Investor News: If You Have Suffered Losses in... Source: Rosen Law Firm

Jul 9, 2026 @ 1:49 AM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Insulet... Source: Rosen Law Firm

Jul 7, 2026 @ 8:53 PM Lead Plaintiff Deadlines in Shareholder Class Acti... Source: Holzer & Holzer, Llc

Jul 6, 2026 @ 2:49 PM Gainey McKenna & Egleston Announces A Class Action... Source: Gainey Mckenna & Egleston

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$4.3	$1.3	$1.44
Diluted EPS	$4.29	$1.3	$1.43
Revenue	$2.9B	$761.7M	$783.8M
Gross Profit	$2.06B	$529.1M	$568.6M
Net Income / Loss	$302.8M	$91.1M	$101.6M
Operating Income / Loss	$507.2M	$122.1M	$146.3M
Cost of Revenue	$841M	$232.7M	$215.2M
Net Cash Flow	$-802.6M	$-235.7M	$-41.3M
PE Ratio